Atlas Trials

A Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil/ Hydrochlorothiazide After a Single Oral Dose Administration Under Fasting Conditions

Clinical trial NCT04138888 · UNKNOWN

Trial details

NCT number
NCT04138888
Sponsor
Pharmtechnology LLC
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Bioequivalence
Start date
2019-10-31
Primary completion
2019-12-24
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.